The relationship between antimicrobial use in livestock and animal welfare is complex and bidirectional. Antibiotics are essential therapeutic tools that prevent and treat bacterial diseases causing suffering; overuse contributes to antimicrobial resistance (AMR) that threatens both animal and human health. Responsible antimicrobial stewardship seeks to maintain antibiotic efficacy for therapeutic welfare purposes while reducing inappropriate use.
Antibiotics as Welfare Interventions
When bacterial disease causes suffering — pneumonia, mastitis, metritis, enteritis — appropriate antibiotic treatment rapidly reduces pain, fever, and systemic illness, providing welfare benefit. The capacity to effectively treat bacterial disease is a cornerstone of veterinary welfare practice. Preserving this capacity by avoiding resistance development is therefore a welfare priority at population scale: if common therapeutic antibiotics become ineffective, animal welfare will suffer from untreatable bacterial infections.
The Antimicrobial Resistance Welfare Risk
Antimicrobial resistance emerges when bacteria evolve mechanisms to survive antibiotic exposure. Widespread use of antibiotics — particularly at subtherapeutic doses for growth promotion, or therapeutically without proper diagnosis — selects for resistant bacteria. Once resistance is established, treating infections with that antibiotic class becomes ineffective, leaving animals to suffer from conditions that would previously have been treatable.
The welfare implications of AMR development in livestock extend to human medicine: resistant bacteria can transfer from animals to humans through the food chain, direct contact, and environmental routes. The One Health framework recognizes that animal, human, and environmental health are interconnected; antimicrobial stewardship in livestock therefore supports human welfare alongside animal welfare.
Stewardship Principles
Evidence-based antimicrobial stewardship in livestock involves: using antibiotics only when clinically justified following proper diagnosis; selecting the narrowest spectrum antibiotic effective for the pathogen; completing appropriate course lengths; avoiding group prophylactic treatment where alternative prevention is possible; and eliminating growth-promotion use entirely. These principles preserve therapeutic efficacy while meeting individual animal welfare needs.
Vaccination as Stewardship
Vaccination programs that prevent bacterial disease reduce the need for therapeutic antibiotic use. Effective vaccines for bovine respiratory disease, swine enzootic pneumonia, clostridiosis, and other major bacterial diseases reduce antibiotic demand while improving welfare by preventing disease rather than treating it. Investment in vaccine development and producer adoption of vaccination programs supports both stewardship and welfare objectives simultaneously.